Anti-Inflammatory Effect of Sulfated Polysaccharides Isolated from Codium fragile In Vitro in RAW 264.7 Macrophages and In Vivo in Zebrafish

Mar Drugs. 2022 Jun 13;20(6):391. doi: 10.3390/md20060391.

Abstract

In this study, the anti-inflammatory activity of sulfated polysaccharides isolated from the green seaweed Codium fragile (CFCE-PS) was investigated in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages and zebrafish. The results demonstrated that CFCE-PS significantly increased the viability of LPS-induced RAW 264.7 cells in a concentration-dependent manner. CFCE-PS remarkably and concentration-dependently reduced the levels of inflammatory molecules including prostaglandin E2, nitric oxide (NO), interleukin-1 beta, tumor necrosis factor-alpha, and interleukin-6 in LPS-stimulated RAW 264.7 cells. In addition, in vivo test results indicated that CFCE-PS effectively reduced reactive oxygen species, cell death, and NO levels in LPS-stimulated zebrafish. Thus, these results indicate that CFCE-PS possesses in vitro and in vivo anti-inflammatory activities and suggest it is a potential ingredient in the functional food and pharmaceutical industries.

Keywords: Codium fragile; RAW 264.7 cells; anti-inflammatory activity; sulfated polysaccharides; zebrafish.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Chlorophyta* / metabolism
  • Lipopolysaccharides* / pharmacology
  • Macrophages
  • Mice
  • NF-kappa B / metabolism
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / metabolism
  • Polysaccharides / pharmacology
  • RAW 264.7 Cells
  • Sulfates / pharmacology
  • Zebrafish / metabolism

Substances

  • Anti-Inflammatory Agents
  • Lipopolysaccharides
  • NF-kappa B
  • Polysaccharides
  • Sulfates
  • Nitric Oxide
  • Nitric Oxide Synthase Type II